Zurich Cantonal Bank’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,073
Closed -$43.4K 2786
2023
Q3
$43.4K Hold
11,073
﹤0.01% 2625
2023
Q2
$112K Buy
11,073
+5,834
+111% +$61.8K ﹤0.01% 2295
2023
Q1
$53.4K Buy
5,239
+2,753
+111% +$31.5K ﹤0.01% 2582
2022
Q4
$23.3K Hold
2,486
﹤0.01% 2737
2022
Q3
$36K Hold
2,486
﹤0.01% 2688
2022
Q2
$33K Hold
2,486
﹤0.01% 2701
2022
Q1
$42K Hold
2,486
﹤0.01% 2564
2021
Q4
$64K Buy
+2,486
New +$77.5K ﹤0.01% 2666

Other funds holding TSVT

Zurich Cantonal Bank's TSVT Position: Q4 2023 in Review

Zurich Cantonal Bank sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 11,073 shares — an estimated $43.4K sold.

Zurich Cantonal Bank first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $112K in Q2 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Zurich Cantonal Bank reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 11,073 2seventy bio shares in Q4 2023, an estimated $43.4K.
  • Zurich Cantonal Bank first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • Zurich Cantonal Bank's 2seventy bio position peaked at $112K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.